Data Integrity in Pharma: The ALCOA+ Guide

2026-06-05

Data integrity in pharma explained through ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available) — the regulations, the common 483 failures, and how to build it in by design.

Data Integrity in Pharma: The ALCOA+ Guide

When the FDA or MHRA inspects a pharmaceutical site, the question underneath almost every other question is the same: can I trust your data? Year after year, data integrity is the single largest source of 483 observations and warning letters — not because companies fake results, but because their records can't prove they didn't.

This guide explains data integrity in pharma through the framework regulators use to judge it — ALCOA+ — and shows how to build records that pass that test by design rather than by hope.

What data integrity means

Data integrity is the degree to which data is complete, consistent, and accurate throughout its entire lifecycle — from the moment it is generated, through processing and reporting, to archival and eventual retrieval. It applies to every GxP record: a balance reading, a chromatogram, a batch record entry, a deviation closure, an equipment log.

A result isn't trustworthy because someone says it happened. It's trustworthy because the record shows who produced it, when, from what, and that nothing was changed without trace. That is what ALCOA+ formalises.

ALCOA — the five core principles

ALCOA is an acronym coined by the FDA. Every GxP record must be:

The "+" — four more that close the gaps

Regulators extended ALCOA to ALCOA+ because the original five left room to wriggle. The additions:

Put together, ALCOA+ is a single test: if an inspector pulled this record cold, could it stand on its own?

The regulations behind it

ALCOA+ isn't a guideline you can opt out of — it's how these binding regulations are enforced:

The failures inspectors actually find

Data integrity citations rarely involve outright fraud. They're usually these patterns:

Notice the common thread: the tool allowed the gap. Paper and spreadsheets can't enforce attribution, contemporaneity, or an audit trail — so integrity depends on people remembering to be disciplined, every time.

Static vs dynamic data — and why metadata matters

Inspectors distinguish two kinds of records:

For dynamic data, the metadata (who, when, what method, what changes) is part of the record. Keeping only a printed chromatogram and discarding the underlying data file destroys integrity, because the printout can't show whether the integration was reprocessed to pass. Complete and original means keeping the data, not just the picture of it.

How to build data integrity in by design

You don't achieve ALCOA+ by training people to be careful. You achieve it by using a system where the un-compliant action is impossible:

How Flobri enforces ALCOA+

Flobri's quality workflows are built so each ALCOA+ principle is a property of the system, not a habit:

The point isn't that the software is careful. It's that the careless path doesn't exist — which is exactly what "data integrity by design" means, and exactly what an inspector is looking for. (See also how to prepare for an FDA or GMP audit with digital documentation.)

Frequently asked questions

What does ALCOA+ stand for?

Attributable, Legible, Contemporaneous, Original, Accurate — plus Complete, Consistent, Enduring, and Available. It's the framework regulators use to assess whether GxP data can be trusted.

What is data integrity in pharma?

The assurance that data is complete, consistent, and accurate throughout its lifecycle — from generation to retrieval — so that records reliably reflect what actually happened.

What is 21 CFR Part 11?

The US FDA regulation governing electronic records and electronic signatures, requiring controls such as unique user IDs, secure and time-stamped audit trails, and system validation so electronic records are as trustworthy as paper.

What is the difference between static and dynamic data?

Static data is a fixed snapshot (a printout or PDF). Dynamic data can be interacted with and reprocessed (a chromatography data file). For dynamic data, the metadata and underlying file are part of the record and must be retained — a printout alone isn't enough.

Why do most data integrity findings happen?

Usually not fraud, but tools that can't enforce the rules — shared logins, missing or disabled audit trails, back-dated paper, and uncontrolled spreadsheets — which leave integrity dependent on people remembering to be disciplined.


Flobri runs OOS, deviation, change control, CAPA, calibration, and batch release as connected, audit-ready workflows with per-user attribution, system timestamps, and an immutable audit trail — data integrity built in, not bolted on. See how Flobri handles pharma quality workflows.

Tags: data integrity in pharmaALCOA+ALCOA principles21 CFR Part 11EU Annex 11MHRA data integrityGMP data integrityaudit traildata integrity guidelines